Reduction in salivary cortisol concentration correlates with resolution of psychosis in Cushing's syndrome.
Myhill
Paul C
PC
Sillars
Brett A
BA
Starkstein
Sergio
S
Annus
Tibor
T
Yeap
Bu B
BB
D000963:Antimetabolites / Q000627:therapeutic use; D003480:Cushing Syndrome / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism*; D008297:Male; D008797:Metyrapone / Q000627:therapeutic use; D008875:Middle Aged; D011618:Psychotic Disorders / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D012463:Saliva / Q000187:drug effects / Q000378:metabolism*; D013223:Statistics as Topic
D000963:Antimetabolites; D006854:Hydrocortisone; D008797:Metyrapone